Group 1: Investor Relations Activities - The company participated in the 2025 online collective reception day for investors in Hubei on June 12, 2025 [3][4] - The event was conducted remotely via the "Panorama Roadshow" website [4] Group 2: Key Issues Addressed - The company is expanding its business into the Huang-Huai-Hai region with multiple new varieties entering the approval stage, aiming to enhance market competitiveness [6] - In the Northeast region, the company is addressing ear rot disease with two main varieties, JN 198 and HSD 568, showing significant disease resistance [6] - Strategic partnerships have been established with research institutions to enhance R&D capabilities in the Northeast [6] Group 3: M&A Plans - The company is considering M&A plans based on industry developments and its own strategic goals, with timely disclosures to be made as required [6]

Group 1: Investor Relations Activity Overview - The investor relations activity was an earnings briefing held on May 21, 2025, from 15:00 to 16:00 [3] - The event was conducted online via www.ir-online.cn, with participation from various investors [3] - Key company representatives included CEO Peng Xubing, Secretary Li Danni, and CFO Deng Huayong [3] Group 2: Industry Challenges and Company Strategy - The corn seed industry is currently facing an oversupply situation, presenting both challenges and opportunities for the company [5] - The company aims to enhance its market share and profitability by focusing on high-yield, resilient new varieties and leveraging transgenic technology [5] - The company is committed to maintaining long-term partnerships with feed enterprises to secure demand [5] Group 3: International Market Expansion - The company is actively exploring international markets, conducting variety trials in Southeast Asia (Cambodia, Pakistan) and Africa (Nigeria, Angola, Madagascar) [5] - The goal is to establish overseas partnerships to promote products and services globally [5] Group 4: Product Development and Market Strategy - The company has successfully developed transgenic corn variety Kangnong 20065KK, which has shown stable performance in trials [7] - Plans are in place to expand production scale and market promotion in the coming year, with over 300 acres already designated for demonstration planting [7] - The company is focusing on building a diverse product matrix in key regions like Huanghuaihai and East North China to enhance competitiveness [8] Group 5: Mergers and Acquisitions Considerations - The company is considering mergers and acquisitions to diversify its business and improve risk resilience, evaluating potential targets based on industry conditions and strategic alignment [6][8] - Any significant developments will be disclosed in accordance with the Beijing Stock Exchange listing rules [6][8] Group 6: Research and Development Collaborations - The company has established strategic partnerships with agricultural research institutions to enhance R&D capabilities in the Northeast region [8] - This collaboration aims to address specific challenges such as disease resistance in corn varieties [8]